Sigachi Laboratories Limited Unlisted Share
₹52▲0.00%(0.00)
About the company
Sigachi Laboratories Limited is an Indian pharmaceutical company engaged in the manufacturing and supply of bulk drugs, drug intermediates, and pharmaceutical products. The company operates from its registered office and manufacturing facility in Sangareddy District, Telangana, and has established its presence in the pharmaceutical sector by focusing on quality manufacturing, regulatory compliance, and operational efficiency.
The company's core business revolves around producing pharmaceutical ingredients that serve as essential building blocks in the manufacturing of medicines. In addition to its pharmaceutical operations, Sigachi Laboratories also generates income from interest on loans, inter-corporate deposits (ICDs), and fixed deposits, contributing to its overall financial performance.
Fundamentals
Valuation
Registry
| Metric | Value |
|---|---|
| PAN number | AACCS8220M |
| ISIN number | INE368H01018 |
Figures in lk ·
Financials
| P&L Statement | 2025Latest | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 312 | 374 | 195 | 260 | 348 | 66 | 169.54 | 176.24 |
| EBITDA | 109 | 242 | 142 | 211 | 293 | 25 | 113.89 | 113.64 |
| OPM | 34.94 | 64.71 | 72.82 | 81.15 | 84.2 | 37.88 | 67.18 | 64.48 |
| PBT | 152 | 281 | 173 | 238 | 314 | 116 | 127.39 | 133.89 |
| PAT | 119 | 197 | 131 | 200 | 276 | 70 | 104.51 | 111.1 |
| EPS | 1.63 | 2.69 | 1.79 | 2.74 | 3.78 | 0.96 | 1.43 | 1.52 |
Shareholding Pattern
| Holder | Percentage |
|---|---|
| Promoters | 36.86% |
| Resident Individual | 40.59% |
| NRI | 20.48% |
| Others | 2.07% |
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Sri. T. Adinarayana | Chairman | 30+ yrs experience | — |
| Sri. T.R. Sekhar | Executive Director | 25+ yrs experience | — |
| Mr. B. Kumar | CFO | 25+ yrs experience | — |
Frequently asked questions
Common questions on Sigachi Laboratories Limited Unlisted Share—tap a row to read the answer.
Q.1What is Sigachi Laboratories Limited?
Sigachi Laboratories Limited is an Indian pharmaceutical company engaged in the manufacturing of bulk drugs, drug intermediates, and other pharmaceutical products. The company also earns income from interest-bearing investments such as inter-corporate deposits (ICDs), loans, and fixed deposits. With its focus on quality manufacturing and operational efficiency, the company serves the pharmaceutical industry's growing demand for active ingredients and intermediates.
Q.2Can I invest in Sigachi Laboratories Limited unlisted shares?
Yes, if Sigachi Laboratories Limited unlisted shares are available in the private market, eligible investors can purchase them through private share transactions. Since these shares are not traded on major stock exchanges, their availability depends on existing shareholders willing to sell and prevailing market demand.
Q.3How can I buy Sigachi Laboratories Limited unlisted shares?
You can buy Sigachi Laboratories Limited unlisted shares through authorized intermediaries that facilitate private share transactions. Once the price, quantity, and documentation are finalized, the shares are transferred electronically to your Demat account after successful payment and verification.
Q.4How is the price of Sigachi Laboratories Limited unlisted shares determined?
The price of Sigachi Laboratories Limited unlisted shares is generally influenced by several factors, including the company's financial performance, profitability, business outlook, pharmaceutical industry trends, recent private market transactions, investor demand, and overall market sentiment. Since the shares are privately traded, prices are determined through negotiations rather than exchange-based trading.
Q.5Is it legal to buy Sigachi Laboratories Limited unlisted shares in India?
Yes. Buying and selling unlisted shares is legal in India when the transaction complies with applicable laws and regulatory requirements. Investors should ensure that the transfer is completed with proper documentation and that the shares are credited to their Demat account.
Q.6Do I need a Demat account to hold Sigachi Laboratories Limited unlisted shares?
Yes. An active Demat account is generally required to receive and hold Sigachi Laboratories Limited unlisted shares in electronic form. It provides secure ownership records and makes future transfers or sales more convenient.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

Top 10 Unlisted Shares in India in 2026: Companies, Fundamentals & What Investors Should Know
Explore 10 unlisted shares in India in 2026, including MSEI, Garuda Aerospace, OYO, Goodluck Defence, 63SATS, NCDEX, API Holdings and more.

Unlisted Share Price List India — Buy and sell Pre-IPO Shares
Unlisted shares pertain to equity shares which are not listed on recognized stock exchanges. This guide explains the mechanics of unlisted shares, the process by which an investor can purchase them, the method of valuation and red flags which should be noted by an investor prior to buying unlisted shares. The article also highlights the differences between listed, unlisted, and pre-IPO shares while discussing the risks such as low liquidity, valuation, business, and IPO risk. The article provides a checklist and frequently asked questions to understand the nuances of unlisted shares.

MSEI, Zepto and Other Pre-IPO Shares Move: 2026 Performance
MSEI surged over 124% while Zepto declined nearly 48% in 2026. Explore how other pre-IPO and unlisted shares performed and what the latest market trends mean for investors.

Sagar Defence Unlisted Share: Price, Financials & Why Investors Are Watching This Defence-Tech Stock
Sagar Defence Engineering's unlisted shares are drawing attention as India's defence-tech push gains momentum. Here's a look at the company, its FY26 numbers, and what to know before investing.

API Holdings & MSEI Unlisted Shares Surge: What’s Driving the Rally?
API Holdings and MSEI unlisted shares are witnessing sharp price movements, attracting fresh investor attention. Discover what is driving the rally, the latest trends and key factors to consider before investing.

NSE IPO Price Band vs NSE Unlisted Share Price — What Is the Difference?
The upcoming NSE IPO has created strong interest around the difference between the -NSE IPO price band and NSE unlisted share price. Recent reports indicate a possible IPO price range of ₹1,700–₹1,785, while NSE unlisted shares were around ₹2,045 on 9 September 2026. This blog explains why these prices can differ and covers NSE’s latest financial performance, valuation, IPO structure, lock-in period, business strengths and key risks investors should understand before evaluating NSE shares.
